Welcome

Dr. CoussensThe overarching mission of the OHSU Department of Cell, Developmental & Cancer Biology is to advance the understanding of problems relevant to human health and disease. To accomplish this mission, research groups in the department have historically focused on questions regarding cell structure, organelles, life cycle, differentiation, and regulated communication between cells and extracellular signals and cues. An ultimate application of knowledge gained from these studies has been to understand important cell physiologic processes that effect human biology. These issues directly link to problems of interest to developmental biologists, including molecular and cellular mechanisms regulating tissue morphogenesis, tissue polarity and patterning. Read more

Upcoming Events

News and Recognitions

Onward Stories:
OHSU Foundation's Onward campaign recently featured three CDCB faculty members, Sudarshan Anand, Ph.D., Amy Moran, Ph.D. and Naoki Oshimori, Ph.D., in the article Chasing Down Cancer

Recent CDCB and Knight Cancer publications:
Lund Lab published IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. The article was highlighted here in Nature Reviews Cancer. 



Knight News:
Congratulations to Lisa Coussens, Ph.D., honored by the American Association for the Advancement of Science as an elected AAAS Fellow for her pioneering studies in tumor biology.


Recent CDCB publications:




OHSU NewsTumor cells fuse with immune cells and become more aggressive. Download the featured published article here


Congratulations to Sudarshan Anand on his NHLB award for A microRNA-target Network in Endothelial DNA Damage and Angiogenesis and a second NHLB award for MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity

Congratulations to Mara Sherman for her NCI award for Identifying and Targeting Metabolic Dependencies in the Pancreatic Tumor

Congratulations to Amy Moran and Julie Graff, awarded $1 million by the Prostate Cancer Foundation to study the effect of intestinal microbiota on responsiveness to prostate cancer immunotherapy treatments. Read more on the O2 blog, Knight News.

View all CDCB news and recognitions.